Therapeutic Asset Ratings
5,108 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cis-Diamminedichloroplatinum Ii
Primary Peritoneal Serous Adenocarcinoma
Ohio State University Comprehensive Cancer Center
P3
BB
(65)
Cis-Diamminedichloroplatinum Ii
Skin Cancer
Toray Industries, Inc
P3
BB
(65)
Cis-Diamminedichloroplatinum Ii
Uterine Cervix Neoplasm
Merck Sharp & Dohme LLC
P3
BB
(65)
Crizotinib
Hepatocellular Carcinoma
Ariad Pharmaceuticals
P3
BB
(65)
Ctt-1057
Prostate Neoplasm
Novartis Pharmaceuticals
P3
BB
(65)
Cyclophosphamide
Breast Carcinoma In Situ
Roswell Park Cancer Institute
P3
BB
(65)
Cyclophosphamide
Myeloproliferative Neoplasm
Sawa Ito, MD
P3
BB
(65)
Cyclophosphamide
Invasive Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(65)
Cyclophosphamide
Non-Cutaneous Melanoma
H. Lee Moffitt Cancer Center and Research Institute
P3
BB
(65)
Cytarabine
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P3
BB
(65)
Cytarabine
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P3
BB
(65)
Cytarabine
T-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
BB
(65)
Cytarabine
T-Lymphoblastic Lymphoma
Children's Oncology Group
P3
BB
(65)
Daratumumab
Smoldering Plasma Cell Myeloma
Regeneron Pharmaceuticals
P3
BB
(65)
Dexasone
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(65)
Docetaxel
Carcinoma Of The Ampulla Of Vater
Minia University
P3
BB
(65)
Docetaxel
Ovarian Brenner Tumor
National Cancer Institute (NCI)
P3
BB
(65)
Docetaxel
Hypogonadism
SWOG Cancer Research Network
P3
BB
(65)
Docetaxel
Ovarian Serous Adenocarcinoma
Genelux Corporation
P3
BB
(65)
Docetaxel
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P3
BB
(65)
Docetaxel
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BB
(65)
Dostarlimab
Ovarian Carcinoma
University of Washington
P3
BB
(65)
Elacestrant
Her2-Receptor Negative Breast Cancer
Kristina A. Fanucci
P3
BB
(65)
Epcoritamab
Diffuse Large B-Cell Lymphoma
Mwanasha Merrill, MD
P3
BB
(65)
Epirubicin
Invasive Breast Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(65)
Showing 1451 to 1475 of 5,108 assets
Previous
Page 59 of 205
Next